Back to search
Autoimmune Gastrointestinal Dysmotility
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Gastrointestinal Dysmotility trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Gastrointestinal Dysmotility trials you may qualify forGastrointestinal motility disorders represent a heterogeneous group of neuromuscular diseases of the enteric nervous systems. While autoimmune neuromuscular dis…
Autoimmune gastrointestinal dysmotility syndromes are poorly understood, and often difficult to treat because the underlying pathogenesis is unclear. Refractory…
The purpose of this study is to evaluate the pharmacodynamic (PD) and pharmacokinetic (PK) profile and the safety and tolerability of RM-131 in patients with di…